A potential caveat for the interpretation of CD38 expression levels obtained from cytometric assays is the reported presence of anti-CD38 autoantibodies in SLE patients that could potentially downregulate CD38 or inhibit the binding of detection antibodies. The gene discussed is CD38; the disease is systemic lupus erythematosus.